Advertisement

Topics

Syndicated Content about Biotechnology, Pharmaceutical and Healthcare

00:23 EST 24th January 2019 | BioPortfolio

Latest global life science, pharmaceutical and healthcare news syndicated from over 50 publishers. 

Showing News Articles 1–25 of 120,000+

Thursday 24th January 2019

Bio-Thera Starts Global Phase III Trial of Arthritis-targeted Biosimilar

Bio-Thera Solutions of Guangzhou has begun dosing rheumatoid arthritis patients in a global Phase III trial of its biosimilar to Genentech’s RoActemra®. Bio-Thera's BAT1806 is one of four Bio-Thera candidates in Phase III trials. The company is developing a portfolio of innovative and biosimilar molecules for various cancers, autoimmune and cardiovascular diseases. Its BLA for a Humira b...

Wednesday 23rd January 2019

Brain modulation and patent law https://go.nature.com/2FTnDH7 

Brain modulation and patent law https://go.nature.com/2FTnDH7 

. @julemieux1 reports on how Cas12b enzyme enhancements will allow for more functional multiplexing -- http://ow.ly/Qu7o30nqc3F 

. @julemieux1 reports on how Cas12b enzyme enhancements will allow for more functional multiplexing -- http://ow.ly/Qu7o30nqc3F 

. @ruhrunibochum scientists eye overexpression of muscle LIM protein as a potential therapeutic strategy for promoting the repair of nerves in the #brain, the optic nerve, and the spinal cord: http://ow.ly/s1X330nqex4 

. @ruhrunibochum scientists eye overexpression of muscle LIM protein as a potential therapeutic strategy for promoting the repair of nerves in the #brain, the optic nerve, and the spinal cord: http://ow.ly/s1X330nqex4 

Insights from robotics and simulated skeletons indicate that prehistoric tetrapods learnt to walk more efficiently on land earlier than previously thought, reports a paper published in Nature. https://go.nature.com/2FyAWgC pic.twitter.com/uWh9LrwWGF

Insights from robotics and simulated skeletons indicate that prehistoric tetrapods learnt to walk more efficiently on land earlier than previously thought, reports a paper published in Nature. https://go.nature.com/2FyAWgC  pic.twitter.com/uWh9LrwWGF

. @SBPdiscovery researchers detail how a targeted therapy shrinks tumors in mice with a form of pediatric #brain #Cancer known as medulloblastoma: http://ow.ly/UQcH30nqcA9 

. @SBPdiscovery researchers detail how a targeted therapy shrinks tumors in mice with a form of pediatric #brain #Cancer known as medulloblastoma: http://ow.ly/UQcH30nqcA9 

Telix Pharmaceuticals Limited: Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership

MELBOURNE, Australia and LIEGE, Belgium, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Advanced Nuclear Medicine Ingredients SA ("ANMI"), a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX:TLX, "T...

Shimadzu LH-40 Liquid Handler and FRC-40 Fraction Collector

The Shimadzu LH-40 Liquid Handler and FRC-40 Fraction Collector are designed to significantly improve capabilities and scalability of the Shimadzu Nexera Prep System. The LH-40 liquid handler can be used both as a fraction collector and an auto-sampler. It enables seamless purity checks through re-injection in order to provide more efficient preparative purification. Up to six FRC-40 fraction col...

Cartherics and ToolGen sign a deal on CAR-T therapy

Australia’s Cartherics and Seoul-based ToolGen have teamed up to bring innovative immunotherapies for cancer a step closer to reality. The deal will allow Cartherics to share its expertise in immunology and stem cell science and ToolGen to use its gene editing technology in a joint research project aimed at boosting the ability of a patient’s immune system to fight cancer. The collaboration ...

Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership

MELBOURNE, Australia and LIEGE, Belgium, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Advanced Nuclear Medicine Ingredients SA (“ANMI”), a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX:TLX, “Telix”) today announced that it has completed the in-licensing of 99mtechnetium-EDDA/HYNIC-Lys(NaI)-Urea-Glu (99mTc-iPSMA), a novel clinical-stage radiopharmaceutical for the imaging of prostat...

. @uiowa researchers find that giving mouse mothers nicotinamide riboside while they are nursing has both physical and behavioral benefits for their pups that last into adulthood: http://ow.ly/u03H30nqcgZ 

. @uiowa researchers find that giving mouse mothers nicotinamide riboside while they are nursing has both physical and behavioral benefits for their pups that last into adulthood: http://ow.ly/u03H30nqcgZ 

. @HopkinsMedicine researchers report on a potentially simple and inexpensive screening for esophageal #Cancer: http://ow.ly/yndq30nqcoi 

. @HopkinsMedicine researchers report on a potentially simple and inexpensive screening for esophageal #Cancer: http://ow.ly/yndq30nqcoi 

Populations of whales, seals, sea otters, manatees and sea turtles are bouncing back under the protection of the US Endangered Species Act, even after decades of habitat destruction and exploitation #ResearchHighlight https://go.nature.com/2HpEmnO 

Populations of whales, seals, sea otters, manatees and sea turtles are bouncing back under the protection of the US Endangered Species Act, even after decades of habitat destruction and exploitation #ResearchHighlight https://go.nature.com/2HpEmnO 

MedCity News to host population health summit in New Orleans

To highlight how better population health will transform healthcare, MedCity News is partnering with New Orleans Business Alliance to bring MedCity INVEST Pop

Accelerated Appproval: US FDA Labeling Guidance Calls Out Surrogate Endpoints Needing ‘Additional Context’

For Indications and Usage section of some drugs, such as anti-cancer agents, it may be enough merely to state that...   

Building on collaborations stretching back six years, @BioNTech_Group to acquire MAB Discovery’s antibody generation unit for an undisclosed price: http://ow.ly/iX9v30nqdBc 

Building on collaborations stretching back six years, @BioNTech_Group to acquire MAB Discovery’s antibody generation unit for an undisclosed price: http://ow.ly/iX9v30nqdBc 

Walgreens Agrees To Oversight, Settles Insulin Pen Overdispensing, Discount Pricing Claims

DOJ settlements totaling $269m resolve two False Claims Act cases; company enters corporate integrity agreement requiring independent review organization to...   

NuCana plc Announces Proposed Public Offering of ADSs

EDINBURGH, United Kingdom, Jan. 23, 2019), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer, announced today that it intends...

Scottish team warns of false data from DNA reading https://www.thenational.scot/news/17377150.scottish-team-warns-of-false-data-from-dna-reading/?ref=twtrec … via @ScotNational #NBTintheNews

Scottish team warns of false data from DNA reading https://www.thenational.scot/news/17377150.scottish-team-warns-of-false-data-from-dna-reading/?ref=twtrec … via @ScotNational #NBTintheNews

US FDA Begins Shuttering Some Operations As User Fee Money Dwindles

Compounding carryover money run out, crippling some activities although inspections will continue; countdown to the end of PDUFA fee balance...   &#

This Colorado startup is rethinking lung cancer screening

The Denver-based company, Eon, offers a cloud-based application for lung cancer screening and incidental nodule management and counts Cleveland Clinic and LifePoint Health among its clients.

Going on @Jeopardy was a moon dream for me. So being able to just set foot on stage, felt like an accomplishment,” says champion @JohnPresloid: http://ow.ly/5rdp30noIEj 

Going on @Jeopardy was a moon dream for me. So being able to just set foot on stage, felt like an accomplishment,” says champion @JohnPresloid: http://ow.ly/5rdp30noIEj 

Neurons surprise researchers with unexpected abilities http://bit.ly/2FSfzXc  via @DiscoverMag #NBTintheNews

Neurons surprise researchers with unexpected abilities http://bit.ly/2FSfzXc  via @DiscoverMag #NBTintheNews

Gujarat leads in manufacturing, quality and compliance

Gujarat, which was on the forefront of the pharmaceutical revolution of India, is still leading the way for the pharmaceutical sector of the country in manufacturing, drugs quality and compliance.

US FDA accepts for review Merck's sNDAs for Pifeltroand Delstrigo

Merck, known as MSD outside the United States and Canada, today announced that the US Food and Drug Administration (FDA) has accepted for review supplemental New Drug Applications (sNDAs) for


Advertisement
Quick Search
Advertisement
Advertisement